Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021

• Yao Rodion Konu,
• Siaka Condé,
• Fifonsi Gbeasor-Komlanvi,
• Arnold Junior Sadio,
• Martin Kouame Tchankoni,
• Joel Anani,
• Alexandra Bitty-Anderson,
• Bisimwa Ruhana Mirindi,
• Fatoumata Binta Tidiane Diallo,
• Moustapha MIjiyawa,
• Anoumou Claver Dagnra,
• Didier Koumavi Ekouevi

Affiliations

Yao Rodion Konu

Bordeaux Population Health Centre, UMR 1219, University of Bordeaux, National Institute for Health and Medical Research (INSERM), Research Institute for Sustainable Development (IRD)

Siaka Condé

Togo Office, World Health Organization (WHO)

Fifonsi Gbeasor-Komlanvi

Département de Santé Publique, Université de Lomé

Arnold Junior Sadio

Département de Santé Publique, Université de Lomé

Martin Kouame Tchankoni

Département de Santé Publique, Université de Lomé

Joel Anani

Togo Office, World Health Organization (WHO)

Alexandra Bitty-Anderson

Bordeaux Population Health Centre, UMR 1219, University of Bordeaux, National Institute for Health and Medical Research (INSERM), Research Institute for Sustainable Development (IRD)

Bisimwa Ruhana Mirindi

Togo Office, World Health Organization (WHO)

Fatoumata Binta Tidiane Diallo

Togo Office, World Health Organization (WHO)

Moustapha MIjiyawa

Ministère de la Santé, de l’Hygiène Publique et de l’accès universel aux soins

Anoumou Claver Dagnra

Laboratoire de Biologie Moléculaire et d’Immunologie (BIOLIM), Université de Lomé

Didier Koumavi Ekouevi

Bordeaux Population Health Centre, UMR 1219, University of Bordeaux, National Institute for Health and Medical Research (INSERM), Research Institute for Sustainable Development (IRD)